Jul. 31 at 11:05 AM
$ABCL
A report released yesterday :
D. Chatterjee / JonesTrading maintained a Buy rating on AbCellera Biologics.
Price target of
$13.00.
Chatterjee is a 5-star analyst with an average return of 43.0% and a 65.9% success rate. That´s not bad. She covers the healthcare sector...
AbCellera Biologics has an analyst consensus of Strong Buy,
with a price target consensus of
$10.20.
Cantor Fitzgerald also maintained in July a Buy rating with a
$11.00 price target.
